Age-related macular degeneration: anti-vascular endothelial growth factor treatment.
Jennifer J ArnoldPublished in: BMJ clinical evidence (2016)
In this systematic overview, we categorised the efficacy for four interventions, based on information relating to the effectiveness and safety of anti-angiogenesis (using aflibercept, bevazicumab, and ranibizumab) and ranibizumab plus photodynamic therapy with verteporfin.